NFE2L2 knockdown or gene disruption also sensitizes lung adenocarcinoma cells, hepatoma cells, rat and human glioma cells, and ovarian cancer cells to ferroptosis (50, 109, 110, 111). The gene discussed is NFE2L2; the disease is central nervous system cancer.